Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
about
Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination.Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studiesComparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.Atenolol is associated with lower day-of-surgery heart rate compared to long- and short-acting metoprolol.Oxidation phenotype and the metabolism and action of beta-blockers.Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamicsA multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteersPolymorphic metabolism of beta-adrenoceptor antagonists.CYP2D6 genotype and its relationship with metoprolol dose, concentrations and effect in patients with systolic heart failure.Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol.Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study.
P2860
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
P2860
Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Comparison of two long-acting ...... thy men during chronic dosing.
@en
Comparison of two long-acting ...... thy men during chronic dosing.
@nl
type
label
Comparison of two long-acting ...... thy men during chronic dosing.
@en
Comparison of two long-acting ...... thy men during chronic dosing.
@nl
prefLabel
Comparison of two long-acting ...... thy men during chronic dosing.
@en
Comparison of two long-acting ...... thy men during chronic dosing.
@nl
P2093
P2860
P1476
Comparison of two long-acting ...... thy men during chronic dosing.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1982.TB04962.X
P407
P577
1982-11-01T00:00:00Z